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Smoking remains a significant health and economic burden in the United States, resulting in 480,000 deaths and
costing more than $300 billion annually1. While many smokers report a desire to quit, most are unsuccessful in
quit attempts2. The tenacity of this addiction can be, in part, attributed to nicotine, the primary addictive constituent in cigarettes3. Notable sex differences related to smoking and quitting have been identified [for a review see4].
While men are more likely to be smokers and smoke more cigarettes per day, women develop dependence to nicotine more rapidly. Women also have higher relapse rates than men and nicotine replacement therapy may be less
effective4–6. These differences may reflect women’s greater sensitivity to non-pharmacokinetic effects of nicotine4,7.
While environmental and social factors likely play a role in some of these nicotine sex differences, biological
factors including the effect of gonadal hormones on nervous system development, changes in circulating gonadal
hormones across the lifespan, and differential expression of X and Y genes have also been implicated8–12. These
factors produce well-described sex differences in the bio-behavioral processes that contribute to drug addiction–
learning and memory, drug efficacy and toxicity, neuroinflammation, etc.13–16. Concomitantly, sex differences in
pre-clinical animal models have also been demonstrated. Females rats show greater nicotine-induced locomotor sensitization, more pronouced withdrawal following nicotine cessation, enhanced conditoned reinforcement
ͷ
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to nicotine-associated cues, and higher break points on a progressive ratio nicotine self-administratin schedule4,17–19. Previous studies have also demonstrated that endogenous neuropeptide experession is sex-dependently
altered following nicotine self-administration20. Tissue levels of neurotensin in the PFC were increased in the
male, but not female, rats following nicotine self-administration compared to saline controls, implicating the PFC
as an area of interest when exploring sex differences related to nicotine intake20.
While nicotine sex differences have been established, a significant gap in knowledge remains regarding the
molecular mechanisms that govern these differences at the transcriptional level. One critical regulator of transcription are microRNAs (miRNAs), which are a family of non-coding RNAs. At the molecular level miRNAs
are about 21–23 nucleotides long and regulate gene expression through direct binding to the 3′ untranslated
region (UTR) of gene targets, thereby inhibiting their translation into protein21. From a pathological perspective,
miRNAs have been shown to regulate an array of important biological functions in several diseases including
neuroadaptive changes within the brain caused by drugs of abuse22–24.
Given the effects of nicotine on brain areas involved in emotional and cognitive processing, we performed RNA-Seq on the prefrontal cortex (PFC) from female and male rats following long-term nicotine
self-administration. The PFC was selected as it is critically involved in higher-order executive function, as well as
regulation of behaviors associated with drug abuse and withdrawal in humans25–27 and non-human animals28–30.
PFC involvement in the modulation of maladaptive behaviors associated with stimulant dependence is well supported, however little is known regarding differential PFC miRNAs expression between sexes in a preclinical
animal model of nicotine taking (i.e., self-administration). Using RNA-Seq technology, which enables rapid
and quantitative profiling of the transcriptome, we profiled the PFC of male and female Sprague Dawley rats
that self-administered nicotine (0.0073 mg/infusion) or received yoked saline infusions for 22 days on a variable ratio 3 (VR3) paradigm to identify differentially expressed miRNAs. Nicotine self-administration in the
females had a more notable effect compared to the males. Among the differentially expressed miRNAs, miR199a and 214, which are both expressed on the same cluster of chromosome 1, were upregulated in the female
rats self-administering nicotine compared to males. This was validated by real time polymerase chain reaction
(RT-PCR). Further, bioinformatics analysis to assess common targets of miR-199/214 identified Sirtuin 1 (SIRT1),
a nicotinamide adenine dinucleotide (NAD)- dependent deacetylase that plays a role in apoptosis, neuron survival, stress resistance, and regulation of drug dependence31–34. Using western-blot, we confirmed expression of
SIRT1 was only downregulated in the brains of nicotine exposed female rats, with no expression change in the
males. To our knowledge, this is the first study to employ nicotine self-administration paradigm coupled with
next generation sequencing technology to identify sex-specific miRNA signatures associated with long term nicotine self-administration. Collectively, our findings highlight a miR-199/214 regulatory network via downregulation of SIRT1 to be associated with nicotine self-administration in females but not males.

Results
 ǦǤ Both male and female rats maintained robust
self-administration of nicotine on a VR3 schedule over the 22 sessions, while yoked-saline maintained very little responding (Fig. 1A). For active lever presses, there was a main effect of Group [F(1,21) = 410.25, p < 0.01]
and Session [F(21,441) = 8.97, p < 0.01] but no effect of Sex (F < 1, p = 0.66). The 3-way Sex x Group x Session
interaction [F(21, 441) = 1.03, p = 0.42] and the 2-way Sex x Group interaction [F(1,21) = 2.28, p = 0.14] were
not significant. The Group x Session interaction was significant [F(21, 441) = 15.00, p < 0.01]. Saline-yoked rats
responded more on session 1, but the nicotine rats responded more on sessions 2 to 22. The Sex x Session interaction was also significant [F(21,441) = 2.30 p < 0.01]; the female rats responded more than males on sessions 1 and
3 with equivalent responding on all other sessions. Responding on the inactive lever quickly decreased (Fig. 1B),
demonstrating a clear discrimination between the active and inactive lever in male and female nicotine rats. For
inactive lever presses, there was a main effect of Session [F(21,441) = 39.01, p < 0.01], but no main effect of Sex
[F(1,21) = 1.79, p = 0.19] or Group [F(1,21) = 1.89, p = 0.18]. The 3-way interaction of Sex x Group x Session
[F(21,441) = 1.49, p = 0.07], the 2-way interaction of Sex x Session [F(21,441) = 1.04, p = 0.40] and the 2-way
interaction of Sex x Group (F < 1, p = 0.43) were not significant. There was a significant interaction of Group x
Session [F(21,441) = 1.66, p < 0.05], with saline-yoked rats responding more on the inactive lever on session 1
and the nicotine rats responding more on the inactive lever on sessions 2, 5, and 11.
Interestingly, when differences in body weight were accounted for, males and females did differ in total nicotine intake [Fig. 2; t(11) = 4.886 p < 0.001]. Females (10.83 ± 0.35 mg/kg) had greater total nicotine intake than
the males (8.01 ± 0.44 mg/kg) (Fig. 2A) when intake over all 22 days are summed. Male and female nicotine rats
displayed an increase in general locomotor activity (Fig. 2B). There were main effects of Group [F(1,21) = 7.12,
p < 0.05] and Session [F(21,441) = 6.21, p < 0.01] but no main effect of Sex (F < 1, p = 0.60). The 3-way Sex x
Group x Session [F(21,441) = 1.07, p < 0.37], the 2-way Sex x Group (F < 1, p = 0.81), and the 2-way Sex x Session
(F < 1, p = 0.68) interactions were not significant. There was a Group x Session interaction [F(21,441) = 3.26,
p < 0.01]; the nicotine rats showed more general locomotor activity than the saline-yoked rats on sessions 2 to 22.
 Ǥ Following completion of the 22
self-administration sessions, total PFC RNA isolated from individual animals was subjected to miRNA sequencing using an RNA-Seq approach to identify differential miRNAs as sex-specific signatures associated with chronic
nicotine exposure. We obtained between 5 and 34 million raw reads per sample per condition and observed an
overall greater than 83% of mapped reads between the sexes (Supplemental Table 1). Among the 688 miRNAs
profiled (Supplemental Table 2), we identified 45 miRNAs, 23 in females and 22 in males, to be differentially
expressed after nicotine self-administration (Fig. 3A). Amongst the 23 miRNAs in females, 10 were up regulated
and 13 down regulated while in the males, 9 were up regulated and 13 down regulated (Table 1). Interestingly, the
overall levels of expression of the differentially expressed miRNAs were more subtle in the males post nicotine
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Figure 1. Nicotine maintained robust self-administration. (A) Active lever presses for females (left panel) and
males (right panel) receiving nicotine infusions on a VR3 schedule of reinforcement (circles) or yoked-saline
infusions (squares). Yoked-saline infusions were administered contingent on responding from a nicotine
partner. That is, yoked rats did not control the saline infusions. (B) Inactive lever presses for females (left panel)
and males (right panel) receiving nicotine infusions on a VR3 schedule of reinforcement (circles) or yokedsaline infusions (squares).

intake. Females, on the contrary, showed enhanced and robust expression of some miRNAs. Further applying a
cutoff of ±1.5 fold change and p < 0.05 as our criteria, we found four miRNAs to be up regulated in the females
post nicotine intake: miR-214-3p (+7.94 fold), miR-350-5p (+4.44), miR-19a-3p (+2.14), and miR-199a-5p
(+1.77). For the males, only miR-451-5p (+1.69) was up regulated. None of the down regulated miRNAs met criteria in the females. However, miR-760-5p (−1.58 fold) was down regulated in the males after nicotine exposure.
Notably, miRs-199 and 214, which are co-expressed on the same cluster of chromosome 1, was significantly
up regulated in female rats exposed to nicotine compared to males that received nicotine. The up regulation
of these miRNAs solely in females self-administering nicotine and not in the males was further validated by
RT-PCR (Fig. 3B). For miR-199a, the 3-way interaction of Sex x Group x Session [F(1,20) = 4.437, p = 0.048],
the 2-way interaction of Sex x Session [F(1,20) = 4.481, p = 0.047] and the 2-way interaction of Sex x Group
[F(1,20) = 5.146 p = 0.035] were significant. Similarly, for miR-214 the the 3-way interaction of Sex x Group x
Session [F(1,16) = 10.14, p = 0.058], the 2-way interaction of Sex x Session [F(1,16) = 10.16, p = 0.006] and the
2-way interaction of Sex x Group (F(1,16) = 5.686, p = 0.030) was significant.

 ͷǦͷͿͿͷͺǤ As miRNAs can regulate the expression of several gene targets,
we performed bioinformatics analysis to assess the common targets of miR-199 and 214 (Supplemental Table 3).
One prominent target we identified was SIRT1 which plays a significant role in cellular processes33. Western blot
analysis on the brain lysates showed a significant decrease in SIRT1 expression in the nicotine exposed female
rats (3-way interaction of Sex x Group x Sesssion F(1,24) = 7.231, p = 0.013) but not in the males (Fig. 4A,B). The
decrease in SIRT1 levels in nicotine self-administering females correlated with increased expression of cleaved
caspase 3, a pro-apoptotic protein (3-way interaction of Sex x Group x Sesssion F(1,24) = 17.81, p < 0.001).
Cleaved caspase did not differ between the male nicotine self-administration and yoked saline controls. To further elucidate if other brain regions unrelated to drug abuse also show sex-specific difference with SIRT1 expression, we examined the cerebellum and hippocampus. We observed no significant change in SIRT1 expression in
both the brain regions with nicotine intake between the two sexes (Supplementary Figs 1 and 2). These data collectively show that down regulation of SIRT1 by nicotine is specific to regions involved in drug seeking and more
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Figure 2. Nicotine intake and locomotor activity. (A) Total nicotine intake throughout self-administration is
displayed for female (closed circle) and male (open circle) rats. (B) Locomotor activity for females (left panel)
and males (right panel) receiving nicotine infusions on a VR3 schedule of reinforcement (circles) or yokedsaline infusions (squares).

Figure 3. Differentially expressed miRNAs and post validation. (A) Venn diagram showing differentially
expressed miRNA between males and females post nicotine self-administration. The color code represents the
expression levels (Red- up and Green – down). (B) Validation of the increase in expression of miR-199a and
miR-214 in female rats that self-administered nicotine compared to saline controls. Overall 2-Way ANOVA
(hatched line) with Sidak’s multiple comparison test (*p < 0.05 and **p < 0.01) was used to determine
significance. ns- not significant.

specifically in female rats. In summary, our current findings demonstrate the co-expressed miRNAs 199 and 214,
and their common gene target SIRT1 to be associated with chronic nicotine taking in female, but not male rats.

 
Studies investigating potential sex differences in nicotine dependence have now begun to document evidence
that women, despite being less prone to smoking, often show more pronounced measures of withdrawal and are
more likely to relapse6,35–38. Using the rodent IV drug self-administration model that mimics human drug-taking
behavior, we allowed male and female rats to self-administer IV nicotine for 22 days. Consistent with our recently
published study20, we found that both male and female rats readily self-administered nicotine. In that study, we
found that female rats had higher total nicotine intake than males (+1.26 fold), although in that study it did not
meet the threshold for statistical significance. In the current report, we observed the same pattern with total
intake in the females significantly higher than the males (+1.35 fold). Higher nicotine intake in females is in line
with previously published works5,17,39–42. One possible reason for the higher intake in females could be the stage
of estrous, which has been associated with the observed sex differences with drugs of abuse43,44. Previous studies
have reported that intact female rats show greater behavioral response to psychostimulants such as cocaine in
estrus compared to other stages of the estrous cycle45 or to males46. This observation further draws support from
another study which showed females reaching higher breaking points during estrus than during other stages of
the estrous cycle on a progressive ratio of cocaine self-administration47.
While there have been reports of some behavioral sex differences associated with chronic nicotine intake, the
molecular mechanisms contributing to these observed sex differences remain poorly explained. The goal of the
current study was to identify sex-specific miRNA signatures associated with chronic nicotine intake. miRNAs
represent a class of noncoding RNAs that critically regulate gene expression by binding to the 3′ UTR of target
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Females

Males
Fold
Change

p-value

miRNA

Fold
Change

rno-miR-214-3p

7.94

4.28E-02

p-value

rno-miR-451-5p

1.69

rno-miR-350-5p

4.44

2.41E-02

4.07E-02

rno-miR-19b-3p

1.35

rno-miR-19a-3p

1.85E-02

2.14

2.07E-02

rno-miR-127-5p

1.3

4.47E-02

rno-miR-199a-5p

1.77

2.62E-02

rno-miR-501-3p

1.28

3.63E-02

rno-miR-378a-5p

1.38

2.74E-02

rno-miR-125a-3p

1.25

3.81E-02

rno-miR-142-3p

1.29

3.08E-02

rno-miR-7a-1-3p

1.22

1.38E-02

rno-miR-344b-5p

1.26

3.98E-02

rno-let-7a-1-3p

1.21

2.17E-02

rno-miR-129-5p

1.2

1.10E-02

rno-miR-20a-5p

1.21

3.55E-02

rno-miR-30d-3p

1.17

1.85E-02

rno-miR-505-3p

1.21

3.82E-02

rno-miR-30c-5p

1.15

4.03E-02

rno-miR-664-3p

1.19

2.86E-02

rno-miR-376c-3p

−1.36

1.37E-02

rno-let-7d-3p

1.17

4.60E-02

rno-miR-151-5p

−1.33

1.55E-02

rno-miR-140-5p

1.16

1.61E-02

rno-miR-376a-3p

−1.33

2.77E-02

rno-miR-369-3p

1.16

3.93E-02

rno-miR-218a-5p

−1.3

2.32E-02

rno-mir-760-5p

−1.58

3.33E-02

rno-miR-376b-3p

−1.26

2.05E-02

rno-miR-374-3p

−1.39

3.74E-02

rno-miR-376b-5p

−1.25

1.21E-02

rno-miR-499-5p

−1.29

9.67E-03

rno-miR-382-3p

−1.23

1.47E-02

rno-miR-24-2-5p

−1.29

1.64E-02

rno-miR-126a-5p

−1.21

1.95E-02

rno-miR-666-5p

−1.23

4.32E-02

rno-miR-31a-5p

−1.21

4.09E-02

rno-miR-488-3p

−1.22

1.07E-02

rno-miR-411-5p

−1.19

6.27E-03

rno-miR-376a-5p

−1.19

3.52E-02

rno-miR-212-3p

−1.15

3.49E-02

rno-miR-873-5p

−1.18

3.73E-02

rno-miR-24-3p

−1.13

3.91E-02

rno-miR-153-3p

−1.13

2.06E-02

rno-miR-136-5p

−1.12

2.82E-02

miRNA

Table 1. Differential miRNAs expression analysis post nicotine self-administration between males and females
(− sign before the number indicates down regulation).

Figure 4. Validation of SIRT1 downregulation in female rats that self administered nicotine. (A) Representative
western blot showing a decrease in SIRT1 expression in the brain lysates of female rats that self-administered
nicotine compared to saline controls. This increase in SIRT1 expression correlated with an increase in cleaved
caspase 3 expression in the brain lysates of female rats that self-administered nicotine compared to saline
controls. Male rats that self-administered nicotine did not differ in SIRT1 and cleaved caspase 3 expression
compared to the saline controls. (B) Quantification of the blots from all the animals used in the study is
represented as a histogram below. Overall 2-Way ANOVA (hatched line) with Sidak’s multiple comparison test
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) was used to determine significance. ns- not significant.

transcripts, thus blocking their translation. Several studies have documented the role of these miRNAs in a plethora of diseases including maladaptive behavior associated with addiction to drugs of abuse22–24. Our current study
did identify differentially expressed miRNAs between male and female rats post nicotine self-administration.
While the relative expression levels of the significantly regulated miRNAs in males were subtle, females showed
more robust changes in expression. The increase in miRNA expression may be a result of the elevated nicotine
intake in the females, including the role of estrous as noted above, compared to the males.
Among the differentially regulated miRNAs in nicotine-taking females, we found miR-199 and 214, which
are co-expressed on chromosome 1, to be up regulated. Co-expression studies showing the implications of miR199a and 214 dysregulation have been very limited. Studies have implicated these miRNAs in several types of
cancers48–50, and their roles have been documented in neural development51,52. Using a self-administration model
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of drug-intake, this study revealed that miR-199a and 214 may serve as novel markers associated with sex differences in nicotine intake. Post-nicotine exposure, females showed a significant increase in both miR-199a and 214
expression compared to the yoked saline controls. In the males, miR-199a was slightly increased in the nicotine
group while miR-214 was decreased, albeit both of these miRNAs did not differ significantly compared to the
saline controls. These findings were validated by RT-PCR.
miRNAs play a critical role in regulating gene expression and can target several gene targets. We performed
a bioinformatics search that identified SIRT1 as one of the common targets for both miR-199a and 214. Western
blot confirmed a significant reduction in SIRT1 in female rats that self-administered nicotine vs females that
were in the saline group, an effect that was not found in the male groups. SIRT1 is a NAD- dependent deacetylase
belonging to the class III histone/protein deacetylases and a member of the silent information regulator family
that has been shown to play a significant role in several cellular processes in a number of diseases33. miRNAs have
been shown to regulate the expression of SIRT1 in different disease models. This includes miR-34a in fatty liver
disease53, miR-195a in lipotoxic cardiomyopathy and diabetic retinopathy54, and miR-199a in cardiac myocyte
hypoxia55. Specific to drug dependence, previous work has notably shown that SIRT1 is upregulated in the NAc
in male mice and rats administered (IP) cocaine, morphine, or heroin34. Although a follow-up study by Ferguson
and collegues31,32 revealed that although the total number of SIRT1 binding sites is increased following 7 days
of IP cocaine injections, drug administration results in depletion of SIRT1 from genic regions, specifically gene
promoters. Divergent results from those studies and the work presented here, are likely a result of the type of drug
utilized, the region of the brain examined, the sex and type of animal model employed, and the drug administration paradigm used.
In terms of neurodegenerative disorders, upregulation of miR-142 has been shown to decrease SIRT1 levels
in a macaque model of neuroAIDS56,57. A recent study demonstrated that upregulation of miR-199a-5p caused
a significant decrease in SIRT1 levels that subsequently led to neuronal loss and apoptosis in a rat model of epilepsy58. The role of SIRT1 in exerting neuroprotection both in vivo and in vitro has been well documented59. In an
Alzheimer’s disease model, overexpression of SIRT1 caused reduction in beta amyloid production and toxicity60
as well as prevented neurotoxic tangles by deacetylating the microtubule binding protein tau61. In Huntington’s
disease, SIRT1 overexpression ameliorates the neurotoxic effect of the mutant protein HTT while overexpression
reverses this effect59. In a rodent model of Parkinson’s disease, overexpression of SIRT1 caused a reduction in
alpha synuclein aggregates and increased longevity while knockout mice displayed opposite effects62.
The current study shows that the upregulation of miR-199 and 214 post-nicotine exposure in female rats
resulted in a significant decrease in SIRT1 levels, which led to an increase in the expression of the pro-apoptotic
protein cleaved caspase 3 in the PFC, but not in the cerebellum and hippocampus. Decreased neuroprotection
specifically in the PFC via SIRT1 in females following long-term nicotine administration may play a role in female
increased vulnerability to nicotine relapse6,38,63 and heighted sensitiveity to nicotine withdrawal4,17–19. Future work
including a yoked-nicotine control will allow careful examination of how nicotine reinforcment, compared to
passive nicotine intake, may alter expression of miRNAs. Additionally, a study holding nicotine intake constant
across sex will allow determination if miRNA expression differences may be a result of differential exposure to
nicotine in males and females. Future directions of this work will also include examining the effect of molecular
manipulation of SIRT1 in the PFC of female and male rats on nicotine self-administration. Further, studies aimed
at dissecting mechanisms associated with the increase in such apoptosis signaling molecules will lend significant
insights into understanding the sex-based differences associated with chronic nicotine intake.



Ǥ Sprague-Dawley rats (14 males; 15 females) were purchased from Harlan Laboratories, Inc.
(Indianapolis, IN, USA) at approximately 9 weeks of age (males 275–300 g; females 175–200 g). Rats were individually housed in clear polycarbonate cages (48.3 × 26.7 × 20.3 cm) lined with TEK-Fresh cellulose bedding.
Rats were allowed ad libitum access to water in home cages throughout the experiment. Following 3 days of
acclimation to the colony room, food was restricted to maintain 90% of a rat’s free-feeding weight. The colony
room was temperature and humidity controlled and maintained on a 12 h:12 h light/dark cycle. All experimental
procedures were performed during the light cycle. Animal procedures and methods employed were approved by
both the University of Nebraska-Lincoln and University of Nebraska Medical Center Institutional Animal Care
and Use Committee in accordance with the relevant guidelines and regulations.
Ǥ Experimental procedures were conducted in 10 conditioning chambers (ENV-008CT; Med
Associates, Georgia, VT), measuring 30.5 × 24.1 × 21.0 cm, enclosed in sound-attenuating cubicles. Each chamber had a variable-speed syringe pump (PMH-100VS; Med-Associates) located outside the cubicle. Tygon tubing was threaded from the pump syringe through a leash into the chamber to be attached to the catheter port.
A recessed receptacle (5.2 × 5.2 × 3.8 cm) was centered on one sidewall of each chamber. A dipper arm could be
raised to provide access to 0.1 ml of 26% (w/v) sucrose in this recessed receptacle. Two retractable levers were
located on each side of the receptacle. A white cue-light (2.54 cm diameter; 28 V, 100-mA) was mounted 7 cm
above each lever and a house-light (two white 28 V, 100-mA lamps) was located in the cubicle, 10 cm above the
chamber ceiling. An infrared emitter/detector unit was located 4 cm above the stainless steel rod floor and 14.5 cm
from the side wall containing the receptacle. The number of times this beam was broken provided a measure of
chamber activity.

®

Ǥ (-)-Nicotine hydrogen tartrate, obtained from Sigma-Aldrich (St. Louis, MO, USA), was dissolved in sterile saline and pH adjusted to 7.0 ± 0.2. Nicotine was infused intravenously at 35.74 µl over 1 sec at 0.0073 mg/infusion (i.e., 0.03 mg/kg/infusion given an average weight of 243 g per rat). Nicotine dose is reported as the free base.
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Ǥ Following acclimation and food restriction, rats were trained to lever press in
our lab’s standard procedure20,64,65. Preliminary lever training sessions were initiated by illumination of the house
light and insertion of one of the two levers (randomly selected). A lever press or a lapse of 15 sec resulted in 4-sec
access to sucrose, lever retraction, and a timeout (average duration = 60 sec; range = 30–89 sec). After the timeout,
one of the two levers was again inserted randomly with the condition that the same lever would not be presented
more than twice in a row. These procedures were repeated until all rats received 60 sucrose deliveries. Daily sessions ranged from 65 to 80 min depending on individual performance. Rats received daily sessions until a lever
press was made on at least 80% of the lever insertions; all rats learned within 3–5 sessions.
  Ǥ Rats were then implanted with indwelling jugular
catheters following our lab’s standard procedures20,64,66. Briefly, rats were anesthetized with a 2:1 ketamine HCl
(100 mg/kg) + xylazine HCl (20 mg/kg) cocktail (IM) and prepped for surgery. Two small incisions were made
below the scapula and the back mount catheter was fit under the skin with the back plate lying flat and the cannula
port exiting the more rostral incision. Another small incision was then made above the right jugular vein and the
catheter tubing pulled subcutaneously from the back, over the shoulder, to the neck. The vein was then isolated
and the catheter tubing fed into the vein and fastened securely. All incisions were then sutured and the rats administered buprenorphine (0.1 mg/kg) for pain maintenance (also administered 24 h post-surgery) and atipamezole
(0.5 mg/kg) to terminate anesthesia. Rats then recovered for 7 days, during which they remained in their home
cages and their catheters were flushed daily with a cocktail of 0.2 ml cefazolin (50 Units/ml) and heparin (30
Units/ml). Patency was checked on the last day of recovery by IV infusion of 0.05 ml xylazine (20 Units/ml).
Rats that displayed ataxia (e.g., impaired locomotor function, sedation) within 20 sec were considered patent. Rats
that were not patent (1 male; 4 females) were excluded from the study.
ǦǤ After recovery, rats received training sessions with sucrose available on a
variable ratio (VR) 3 schedule; on average every third response was reinforced (range 1–5 presses). This training
consisted of 3 daily sessions; during which 1 of the 2 levers was extended into the chamber and then retracted
following requisite responding. Requisite responding resulted in 4-sec access to sucrose. After sucrose access,
the opposite lever was inserted and functioned as the active lever. This process was repeated until the end of the
1-h session. These procedures produce robust lever responding with each lever having an equivalent learning
history65.
ǦǤ Prior to the self-administration phase of the experiment, female and male rats
were separated into two groups creating a total of 4 groups (sample size from post-patency test): nicotine
self-administration groups (nic-males, n = 7; nic-females, n = 6) and saline-yoked groups (sal-males, n = 6;
sal-females, n = 5). During self-administration sessions (1 h) both levers were inserted to begin the session. Rats
in the nicotine self-administration groups received nicotine infusions following responding on 1 of the 2 levers;
responding on the other lever was recorded but held no programed consequence (i.e., only pressing on the active
lever was reinforced). Assignment of active and inactive lever was counterbalanced for all groups. The schedule
of reinforcement in the self-administration phase was again a VR 3. Following the nicotine infusion, a 20-sec
timeout was signaled by the house light turning on and extraction of the levers. Levers were again inserted and
the house light turned off following the timeout. Rats in the saline-yoked groups were presented with two inactive
levers (i.e., responding was recorded but pressing held no programed consequence). Saline-yoked rats received
saline infusions and signaled timeouts matched to a nicotine self-administering partner’s response pattern. This
procedure produced controls that had equated handling, chamber exposure, time-outs, etc. yet they were void
of nicotine exposure. Self-administration sessions were conducted daily for 22 days. Brains were extracted 24 h
after the last self-administration session. Individual brain regions were immediately dissected, rapidly frozen, and
stored at −80 °C until further use.

Ǥ Active lever pressing, inactive lever pressing, and activity were the dependent measures utilized during the self-administration phase. Nicotine intake controlling for body weight was calculated
by the equation: nicotine intake = [(group average weight (g) used to calculate dose/rat’s weight (g) on each
self-administration day) * 0.03 mg * infusions earned]. Using this calculation, we were able to keep the dose of
nicotine per infusion constant and still properly assess possible differences in total nicotine intake20. Total nicotine intake was calculated by summing nicotine intake on all self-administration sessions.
 ǡ ǡǦǤ Total RNA
from the PFC was isolated from individual rats from both sexes and treatment groups using the Direct-Zol
RNA kit (Zymo Research, USA) based on the manufacturer’s protocol. Quantitation of extracted total RNA
used Nanodrop 1000 (Thermo Fisher Scientific Inc., USA) and RNA integrity was determined by Agilent 2100
Bioanalyzer (Agilent Technology, USA). RNA samples were then sent on dry ice to LC Sciences (Houston, TX,
USA) for miRNA sequencing. Briefly, total RNAs with a RIN value >7 were selected for library construction.
A small RNA library was generated from the sample using the Illumina Truseq Small RNA Preparation kit
according to Illumina’s TruSeq Small RNA Sample Preparation Guide. The purified cDNA library was used
for cluster generation on Illumina’s Cluster Station and then sequenced on the Illumina HiSeq platform. Raw
sequencing reads (50 nt) were obtained using Illumina’s Sequencing Control Studio software version 2.8 (SCS
v2.8) following real-time sequencing image analysis and base-calling by Illumina’s Real-Time Analysis version
1.8.70 (RTA v1.8.70).
After trimming the adaptor sequence from the raw reads, mappable reads with the length ranging from 15
to 32 bases were mapped to miRBase v21 and the rat genome. Reads mapped to rat miRNAs in miRbase were
annotated and the number of mapped reads counted for each identified rat miRNA. The raw counts of reads were
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normalized by the library size parameter of the corresponding sample. The library size parameter is a median
value of the ratio between the counts of a specific sample and a pseudo-reference sample. A count number in the
pseudo-reference sample is the count geometric mean across all samples and was calculated using the formula


cij

Sj = median m

m
1/
i
 (∏k=1 cik) 

where Sj is the library size parameter; cij is the count number of sequence i of sample j; m is the total number of
samples involved.

Ǥ TaqMan miRNA and Gene Expression Assays (Life Technologies, Carlsbad,
CA, USA) were used for cDNA synthesis and real time PCR according to manufacturer’s instructions. Small
nuclear RNA U6 (U6) was used as a control for miRNA studies and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was used as a control for mRNA studies. Delta-delta Ct method67 was used to calculate fold change
(2−((CtmiRNA − CtU6)exp − (CtmiRNA − CtU6)control)) or (2−((CtmRNA − CtGAPDH)exp − (CtmRNA − CtGAPDH)control)). Statistical significance was determined using ∆Ct values (CtmiRNA − CtU6) or (CtmRNA − CtGAPDH).
 Ǥ The detailed sequence information of miR-199 and miR-214 was extracted from
miRBase (Release 21)68,69. Targets for miR-199 and miR-214-3p were identified using experimentally validated
miRNA-target interaction database - miRTarBase (Release 6.0)70,71. TargetScan72,73 was used to predicted additional targets for miR-199-5p and miR-214-3p.
Ǥ Western blot using SDS-PAGE electrophoresis was performed using NuPAGE gel system
(Invitrogen) as described in our previous studies74,75. Briefly, 30 µg (SIRT1) and 10 µg (cleaved caspase 3) of
PFC brain lysates from all the animals were separated on a 4–12% and 10% Bis-Tris gels respectively under
reducing conditions followed by transfer and immunodetection. Nonspecific antibody binding was blocked
using Superblock (Thermofisher Scientific, Rockford, IL, USA) for 1 h at room temperature. Immunoblotting
was carried out with antibodies against SIRT1 (1∶1000, Santa Cruz Biotechnology, Santa Cruz, CA) and cleaved
caspase-3 (1: 1000, Cell Signaling,Technology, Danvers, MA) followed by secondary antibody (1∶3,000 HRP
conjugated anti rabbit IgG for SIRT1 and 1∶3000 HRP conjugated anti rabbit for cleaved caspase-3 respectively
(Thermofisher Scientific, Rockford, IL, USA). Blots were developed with 1∶1 solution of Super Signal West Pico
Chemiluminescent Substrate and Luminol/Enhancer (Thermo Fisher Scientific, Rockford, IL, USA).
 Ǥ Active lever presses, inactive lever presses, and chamber activity were analyzed by
separate 3-way mixed measures ANOVAs (Type III Sum of Squares) with Sex (male vs female) and Group (nicotine vs saline) as between-subjects factors and Session (22) as a within-subjects factor. An independent samples t test was used to analyze differences in total nicotine intake between females and males in the nicotine
self-administration groups. Least Significant Difference (LSD) tests were utilized for post-hoc analysis. Statistical
significance was declared at p < 0.05. For miRNA analysis, after normalization, a student t-test was done to identify miRNAs showing significant differences between groups (saline versus nicotine for each of the sex). miRNAs
were filtered using False Discovery Rates (FDR) ≤ 5% and p < 0.05 were considered significant. For the western
blots, 2-way ANOVA followed by Sidak’s multiple comparision test with p < 0.05 was considered significant. All
statistical tests were performed with GraphPad Prism (La Jolla, CA, USA); data represented as Mean ± SEM on
the graphs.


Most of the data generated or analyzed during this study are included in this published article (and its Supplementary Information file). All datasets generated during and/or analyzed in the current study are available from the
corresponding author on reasonable request. All Med-PC programs used to control the behavioral equipment are
available upon request to RAB at rbevins1@unl.edu.
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